General & Plastic Surgery Devices - Italy

The projected revenue in the General & Plastic Surgery Devices market market in Italy is estimated to reach US$687.90m in 2024.
It is expected that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of 3.33%, leading to a market volume of US$810.50m by 2029.
When compared globally, the United States is anticipated to generate the highest revenue with US$9.84bn in 2024.
Italy's General & Plastic Surgery Devices market is experiencing a surge in demand due to the country's rich history of art and beauty.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in Italy is experiencing steady growth due to the increasing demand for cosmetic and reconstructive surgeries.

Customer preferences: Italian customers are increasingly opting for cosmetic surgeries to enhance their appearance and boost their self-confidence. The desire for a youthful appearance and the influence of media and celebrities are driving the demand for procedures such as breast augmentation, liposuction, and facelifts. Additionally, reconstructive surgeries are also in demand, especially among individuals who have undergone trauma or have congenital abnormalities.

Trends in the market: One of the key trends in the General & Plastic Surgery Devices market in Italy is the growing popularity of minimally invasive procedures. Patients are increasingly opting for less invasive techniques that offer faster recovery times and minimal scarring. This trend is driving the demand for devices such as lasers, injectables, and non-surgical skin tightening devices. Another trend in the market is the increasing adoption of advanced technologies. Italian surgeons are embracing innovative surgical devices and techniques to achieve better outcomes and improve patient satisfaction. For example, the use of 3D imaging technology in plastic surgery is gaining popularity as it allows surgeons to visualize the desired results and plan the procedure more accurately.

Local special circumstances: Italy has a well-established healthcare system, which includes both public and private hospitals. The availability of specialized plastic surgery clinics and well-trained plastic surgeons contributes to the growth of the market. Additionally, the country's reputation for high-quality healthcare attracts medical tourists from around the world, further boosting the demand for General & Plastic Surgery Devices.

Underlying macroeconomic factors: Italy's economy plays a significant role in the growth of the General & Plastic Surgery Devices market. As the economy improves, individuals have more disposable income to spend on elective procedures. Additionally, the aging population in Italy is driving the demand for anti-aging treatments and procedures, further contributing to the growth of the market. In conclusion, the General & Plastic Surgery Devices market in Italy is experiencing steady growth due to customer preferences for cosmetic and reconstructive surgeries, the adoption of minimally invasive procedures, the use of advanced technologies, the availability of specialized clinics and well-trained surgeons, and the underlying macroeconomic factors such as the improving economy and aging population.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.